We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$7.45B
AUM Growth
+$600M
Cap. Flow
+$485M
Cap. Flow %
6.51%
Top 10 Hldgs %
47.64%
Holding
120
New
28
Increased
23
Reduced
22
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 19.32%
2 Communication Services 16.41%
3 Technology 11.04%
4 Industrials 9.98%
5 Consumer Discretionary 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXLL
76
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$6.31M 0.08%
175,000
-219,890
-56% -$8.77M
MIG
77
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
$6.06M 0.08%
704,617
SFUN
78
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$5.09M 0.07%
12,100
ADAP
79
DELISTED
Adaptimmune Therapeutics
ADAP
$4.58M 0.06%
+250,000
New +$4.29M
OCUL icon
80
Ocular Therapeutix
OCUL
$1.83B
$4.52M 0.06%
+215,000
New +$5.33M
EJ
81
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$4.15M 0.06%
617,500
LAMR icon
82
Lamar Advertising Co
LAMR
$15.9B
$4.05M 0.05%
70,500
-473,389
-87% -$28.2M
OVTI
83
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$3.14M 0.04%
119,748
-421,123
-78% -$11.3M
CPA icon
84
Copa Holdings
CPA
$5.9B
$2.79M 0.04%
33,781
-168,719
-83% -$16.1M
LPG icon
85
Dorian LPG
LPG
$1.97B
$2.63M 0.04%
157,833
-577,696
-79% -$8.15M
FOMX
86
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.74M 0.02%
+170,000
New +$1.88M
CYAD
87
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1.56M 0.02%
+30,000
New +$1.61M
AVGO icon
88
CALL
Broadcom
AVGO
$1.86T
$1.2M 0.02%
+90,000
New +$1.18M
EVFM
89
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.13M 0.02%
1,389
ADVM
90
DELISTED
Adverum Biotechnologies
ADVM
$1.06M 0.01%
6,500
HELI
91
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$220K ﹤0.01%
8,227
-106
-1% -$4.31K
CCEP icon
92
Coca-Cola Europacific Partners
CCEP
$47.6B
-1,917,500
Closed -$84.8M
DG icon
93
Dollar General
DG
$28.3B
-1,125,000
Closed -$84.8M
BRSL
94
Brightstar Lottery PLC
BRSL
$1.86B
-12,346,124
Closed -$215M
KO icon
95
CALL
Coca-Cola
KO
$374B
-1,000,000
Closed -$40.5M
EIGR
96
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-89
Closed -$758K
MDRX
97
DELISTED
Veradigm Inc. Common Stock
MDRX
-250,000
Closed -$2.99M
CBL
98
DELISTED
CBL& Associates Properties, Inc.
CBL
-560,000
Closed -$11.1M
ESRX
99
DELISTED
Express Scripts Holding Company
ESRX
-223,000
Closed -$19.4M
BGC
100
DELISTED
General Cable Corporation
BGC
-438,050
Closed -$7.55M

Similar funds

Farallon Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Farallon Capital Management held 120 positions worth $7.45B, up 8.8% from $6.85B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management deployed $485M of net new capital in Q2 2015, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was CATAMARAN CORP COM STK (CDA): 6,817,500 shares worth $416M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 9.9% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Hudson Pacific Properties, an estimated $157M trimmed.

  • Farallon Capital Management's largest Q2 2015 buy was CATAMARAN CORP COM STK (CDA): 6,817,500 shares worth $416M.
  • Farallon Capital Management added most to HOSPIRA INC in Q2 2015, an estimated $458M increase.
  • Farallon Capital Management's biggest Q2 2015 reduction was Hudson Pacific Properties, cutting an estimated $157M.
  • Farallon Capital Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $498M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $7.45B portfolio in Q2 2015.
  • Farallon Capital Management opened 28 new positions and closed 26 in Q2 2015.
  • Farallon Capital Management's portfolio value rose 8.8% quarter-over-quarter to $7.45B.

Based on Farallon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.